No profile data available.
Cingulate Inc. (CING) is a healthcare company in the brain and nerve treatment drugs industry, based in Kansas City, United States, with about 14 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $71.11 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
$71.11 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Cognition Therapeutics, Inc. (CGTX), MediciNova, Inc. (MNOV), Gain Therapeutics, Inc. (GANX), Alterity Therapeutics Limited (ATHE).